Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNYNF) Short term Debt (2016 - 2025)

Historic Short term Debt for Sanofi (SNYNF) over the last 17 years, with Q4 2025 value amounting to $5.1 billion.

  • Sanofi's Short term Debt rose 1238.45% to $5.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.1 billion, marking a year-over-year increase of 1238.45%. This contributed to the annual value of $4.9 billion for FY2025, which is 771.24% up from last year.
  • Per Sanofi's latest filing, its Short term Debt stood at $5.1 billion for Q4 2025, which was up 1238.45% from $8.3 billion recorded in Q2 2025.
  • Sanofi's Short term Debt's 5-year high stood at $9.9 billion during Q2 2024, with a 5-year trough of $2.2 billion in Q4 2023.
  • Over the past 5 years, Sanofi's median Short term Debt value was $4.4 billion (recorded in 2024), while the average stood at $4.9 billion.
  • Per our database at Business Quant, Sanofi's Short term Debt tumbled by 4833.18% in 2023 and then skyrocketed by 10441.41% in 2024.
  • Sanofi's Short term Debt (Quarter) stood at $3.6 billion in 2021, then increased by 16.95% to $4.3 billion in 2022, then crashed by 48.33% to $2.2 billion in 2023, then skyrocketed by 104.41% to $4.5 billion in 2024, then increased by 12.38% to $5.1 billion in 2025.
  • Its Short term Debt stands at $5.1 billion for Q4 2025, versus $8.3 billion for Q2 2025 and $4.5 billion for Q4 2024.